SANGAMO THERAPEUTICS INC
SGMO
SGMO was delisted on the 4th of May, 2026.
190 hedge funds and large institutions have $476M invested in SANGAMO THERAPEUTICS INC in 2020 Q1 according to their latest regulatory filings, with 32 funds opening new positions, 64 increasing their positions, 47 reducing their positions, and 31 closing their positions.
36% more repeat investments, than reductions
Existing positions increased: 64 | Existing positions reduced: 47
18% more call options, than puts
Call options by funds: $7.91M | Put options by funds: $6.71M
3% more first-time investments, than exits
New positions opened: 32 | Existing positions closed: 31
2% less funds holding
Funds holding: 193 → 190 (-3)
3.54% less ownership
Funds ownership: 67.7% → 64.16% (-3.5%)
28% less capital invested
Capital invested by funds: $657M → $476M (-$181M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EC
EcoR1 Capital
San Francisco,
California
|
+$17.1M |
| 2 |
TCM
Tang Capital Management
San Diego,
California
|
+$15.1M |
| 3 |
Millennium Management
New York
|
+$11M |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$7.67M |
| 5 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$4.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$64.8M |
| 2 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$11.5M |
| 3 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
-$11.3M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$8.85M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$4.09M |
SGMO Hedge Fund Activity: Q1 2020 in Review
190 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in SANGAMO THERAPEUTICS INC (SGMO) for Q1 2020, worth a combined $476M — down 28% from $657M a quarter earlier.
Buyers outnumbered sellers: 32 funds opened new SGMO positions and 31 closed out — a net gain of 1 holder — while 64 added to existing stakes and 47 trimmed.
The largest buyer was EcoR1 Capital, opening a new position worth an estimated $17.1M. The largest seller was Wellington Management Group, exiting entirely with an estimated $64.8M sold.
- 190 institutional investors held SANGAMO THERAPEUTICS INC (SGMO) as of Q1 2020, down from 193 in Q4 2019.
- Funds reported $476M of SANGAMO THERAPEUTICS INC stock for Q1 2020, down 28% quarter-over-quarter.
- 32 funds opened new SANGAMO THERAPEUTICS INC positions in Q1 2020 and 31 closed out, a net change of +1 holder.
- The largest SANGAMO THERAPEUTICS INC buyer in Q1 2020 was EcoR1 Capital, an estimated $17.1M added.
- The largest SANGAMO THERAPEUTICS INC seller in Q1 2020 was Wellington Management Group, an estimated $64.8M sold.
Based on aggregated 13F filings for Q1 2020.